NGF and multiple sclerosis: Interferon beta (INF-β) therapy, which reduces the rate of clinical relapse and the frequency of lesions in patients with multiple sclerosis, has been shown to promote NGF and NT secretion early in the course of this disease, leading to better clinical effects in those patients who presented a significant increase in NTs [198,199,200].